BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 32317828)

  • 1. The Association of Obesity and Microvascular Complications with Glycemic Control in Patients with Type 2 Diabetes Mellitus.
    Bijelic R; Balaban J; Milicevic S; Sipka SU
    Med Arch; 2020 Feb; 74(1):14-18. PubMed ID: 32317828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation Between Extracutaneous Microvascular Complications and Diabetic Foot Ulcers in Patients with Type 2 Diabetes Mellitus.
    Balaban J; Bijelic R; Milicevic S; Stanetic K; Grbic N
    Med Arch; 2020 Dec; 74(6):444-449. PubMed ID: 33603269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Moram CBM; Salles GF
    Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood glucose control and microvascular and macrovascular complications in diabetes.
    Hanssen KF
    Diabetes; 1997 Sep; 46 Suppl 2():S101-3. PubMed ID: 9285509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial.
    Abraira C; Duckworth W; McCarren M; Emanuele N; Arca D; Reda D; Henderson W;
    J Diabetes Complications; 2003; 17(6):314-22. PubMed ID: 14583175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidences of Severe Hypoglycemia and Diabetic Ketoacidosis and Prevalence of Microvascular Complications Stratified by Age and Glycemic Control in U.S. Adult Patients With Type 1 Diabetes: A Real-World Study.
    Pettus JH; Zhou FL; Shepherd L; Preblick R; Hunt PR; Paranjape S; Miller KM; Edelman SV
    Diabetes Care; 2019 Dec; 42(12):2220-2227. PubMed ID: 31548241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycemic Variability and Vascular Complications in Patients with Type 2 Diabetes Mellitus.
    Caprnda M; Mesarosova D; Ortega PF; Krahulec B; Egom E; Rodrigo L; Kruzliak P; Mozos I; Gaspar L
    Folia Med (Plovdiv); 2017 Sep; 59(3):270-278. PubMed ID: 28976897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Triglyceride/HDL Ratio and Triglyceride Glucose Index as Predictors of Glycemic Control in Patients with Diabetes Mellitus Type 2.
    Babic N; Valjevac A; Zaciragic A; Avdagic N; Zukic S; Hasic S
    Med Arch; 2019 Jun; 73(3):163-168. PubMed ID: 31404127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic memory: Evolving concepts.
    Misra A; Bloomgarden Z
    J Diabetes; 2018 Mar; 10(3):186-187. PubMed ID: 29091343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-world evidence of glycemic control among patients with type 2 diabetes mellitus in India: the TIGHT study.
    Borgharkar SS; Das SS
    BMJ Open Diabetes Res Care; 2019; 7(1):e000654. PubMed ID: 31413840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time to Reach Target Glycosylated Hemoglobin Is Associated with Long-Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Year Observational Study.
    Kim KJ; Choi J; Bae JH; Kim KJ; Yoo HJ; Seo JA; Kim NH; Choi KM; Baik SH; Kim SG; Kim NH
    Diabetes Metab J; 2021 May; 45(3):368-378. PubMed ID: 33081424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relation between plasma endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with Type 2 diabetes mellitus.
    Ak G; Buyukberber S; Sevinc A; Turk HM; Ates M; Sari R; Savli H; Cigli A
    J Diabetes Complications; 2001; 15(3):150-7. PubMed ID: 11358684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant macro and microvascular complications in diabetic nephropathy.
    Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycemic control and the risk of multiple microvascular diabetic complications.
    Schellhase KG; Koepsell TD; Weiss NS
    Fam Med; 2005 Feb; 37(2):125-30. PubMed ID: 15690253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Short-term and long-term glycemic variability and its relationship to microvascular complications of diabetes].
    Prázný M; Škrha J; Šoupal J; Škrha J
    Vnitr Lek; 2016; 62(11 Suppl 4):S85-93. PubMed ID: 27921431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study).
    Laiteerapong N; Ham SA; Gao Y; Moffet HH; Liu JY; Huang ES; Karter AJ
    Diabetes Care; 2019 Mar; 42(3):416-426. PubMed ID: 30104301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity, clinical, and genetic predictors for glycemic progression in Chinese patients with type 2 diabetes: A cohort study using the Hong Kong Diabetes Register and Hong Kong Diabetes Biobank.
    Jiang G; Luk AO; Tam CHT; Lau ES; Ozaki R; Chow EYK; Kong APS; Lim CKP; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JYY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung SKS; Cheng YL; Chow CC; Pearson ER; So WY; Chan JCN; Ma RCW; ;
    PLoS Med; 2020 Jul; 17(7):e1003209. PubMed ID: 32722720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of abnormal cardiovascular autonomic function measured by frequence domain analysis of heart rate variability and conventional tests in patients with type 1 diabetes.
    Mäkimattila S; Schlenzka A; Mäntysaari M; Bergholm R; Summanen P; Saar P; Erkkilä H; Yki-Järvinen H
    Diabetes Care; 2000 Nov; 23(11):1686-93. PubMed ID: 11092293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between β-cell function, metabolic control, and microvascular complications in type 2 diabetes mellitus.
    Zhao L; Ma J; Wang S; Xie Y
    Diabetes Technol Ther; 2015 Jan; 17(1):29-34. PubMed ID: 25574593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Intensive Glycemic Control on Clinical Outcomes Among Patients With Type 2 Diabetes With Different Levels of Cardiovascular Risk and Hemoglobin A
    Tian J; Ohkuma T; Cooper M; Harrap S; Mancia G; Poulter N; Wang JG; Zoungas S; Woodward M; Chalmers J
    Diabetes Care; 2020 Jun; 43(6):1293-1299. PubMed ID: 32193249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.